StockData
Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc (TNDM) stock

TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3026% below fair value
$17.46+0.66 (+3.93%)

Close on Nov 20, 2026Market cap $1.21BP/E –Yield –

Tandem Diabetes Care free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Tandem Diabetes Care's free cash flow for the twelve months ending Jun 30, 2026 was -$26.62M. For fiscal 2025 it was -$29.67M, down 694.1% from the year before. The highest annual figure on record is $97.18M in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$29.67M-694.1%
FY2024Dec 31, 2024$4.99M–
FY2023Dec 31, 2023-$58.61M-458.1%
FY2022Dec 31, 2022$16.37M-83.2%
FY2021Dec 31, 2021$97.18M–
FY2020Dec 31, 2020-$2.74M-112.2%
FY2019Dec 31, 2019$22.37M–
FY2018Dec 31, 2018-$11.31M–
FY2017Dec 31, 2017-$71.85M–
FY2016Dec 31, 2016-$70.10M–
FY2015Dec 31, 2015-$64.53M–
FY2014Dec 31, 2014-$65.78M–
FY2013Dec 31, 2013-$51.77M–
FY2012Dec 31, 2012-$38.00M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$38.68M–
Q1 FY2026Mar 31, 2026$4.79M–
Q4 FY2025Dec 31, 2025$3.10M-59.4%
Q3 FY2025Sep 30, 2025$4.17M-80.6%
Q2 FY2025Jun 30, 2025-$15.70M–
Q1 FY2025Mar 31, 2025-$21.24M–
Q4 FY2024Dec 31, 2024$7.65M–
Q3 FY2024Sep 30, 2024$21.54M–
Q2 FY2024Jun 30, 2024-$11.74M–
Q1 FY2024Mar 31, 2024-$12.45M–
Q4 FY2023Dec 31, 2023-$12.42M-6532.6%
Q3 FY2023Sep 30, 2023-$5.35M-152.2%
Q2 FY2023Jun 30, 2023-$13.70M–
Q1 FY2023Mar 31, 2023-$27.15M-343.4%
Q4 FY2022Dec 31, 2022$193.00K-98.6%
Q3 FY2022Sep 30, 2022$10.23M-67.0%
Q2 FY2022Jun 30, 2022-$5.22M-119.3%
Q1 FY2022Mar 31, 2022$11.16M-55.7%
Q4 FY2021Dec 31, 2021$13.89M+24.7%
Q3 FY2021Sep 30, 2021$31.05M+297.9%
Q2 FY2021Jun 30, 2021$27.08M+374.0%
Q1 FY2021Mar 31, 2021$25.16M–
Q4 FY2020Dec 31, 2020$11.14M-12.2%
Q3 FY2020Sep 30, 2020$7.80M-57.6%
Q2 FY2020Jun 30, 2020$5.71M–
Q1 FY2020Mar 31, 2020-$27.40M–
Q4 FY2019Dec 31, 2019$12.69M-4.2%
Q3 FY2019Sep 30, 2019$18.40M–
Q2 FY2019Jun 30, 2019-$3.19M–
Q1 FY2019Mar 31, 2019-$5.53M–
Q4 FY2018Dec 31, 2018$13.25M–
Q3 FY2018Sep 30, 2018-$4.47M–
Q2 FY2018Jun 30, 2018-$7.30M–
Q1 FY2018Mar 31, 2018-$12.79M–
Q4 FY2017Dec 31, 2017-$13.06M–
Q3 FY2017Sep 30, 2017-$19.26M–
Q2 FY2017Jun 30, 2017-$16.08M–
Q1 FY2017Mar 31, 2017-$23.46M–
Q4 FY2016Dec 31, 2016-$16.33M–
Q3 FY2016Sep 30, 2016-$20.29M–

More Tandem Diabetes Care figures

See a number that looks wrong?